Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NPI 1023354040
NPI deactivated

1023354040

1023354040 was paid $545K by Medicaid between Jan 2018 and Oct 2019, across 47 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 30% of everything it billed.

33Billing provider info1023354040
33aNPI1023354040
33bProvider type—
28Total paid$545K
24GClaims73,342
24DCodes billed47
24AFirst – last monthJan 2018 – Oct 2019
Box 24A · Dates of service

Paid by month

$0$20K$40K$60K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201841,635$378K
201931,707$166K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 30% 13,285 8,181 $165K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 17% 9,702 4,666 $94K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 11% 3,467 2,827 $58K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 8.1% 803 665 $44K
80321 2.0% 3,160 2,195 $11K
80373 1.7% 2,398 1,629 $9K
80346 1.7% 2,590 1,771 $9K
80372 1.7% 2,339 1,595 $9K
80348 1.6% 3,200 2,251 $9K
80362 1.6% 2,992 2,149 $9K
80324 1.6% 2,451 1,724 $9K
80369 1.6% 2,337 1,588 $9K
35 more codes
80368 1.6% 2,323 $9K
80354 1.6% 2,471 $9K
80358 1.5% 2,354 $8K
80356 1.5% 2,364 $8K
80365 1.5% 2,256 $8K
80361 1.5% 2,340 $8K
80345 1.4% 2,350 $8K
80359 1.3% 1,575 $7K
80353 1.3% 1,391 $7K
80355 1.1% 613 $6K
80366 1.1% 583 $6K
80349 1.1% 1,083 $6K
80360 <1% 88 $4K
83992 <1% 1,327 $4K
80367 <1% 94 $4K
80357 <1% 61 $3K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 283 $2K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 458 $1K
80336 <1% 13 $1K
80050 General health panel <1% 76 $275.30
80061 Lipid panel <1% 118 $270.36
80363 <1% 14 $248.49
82670 <1% 44 $161.25
82627 <1% 46 $128.33
83001 <1% 46 $107.24
83002 <1% 45 $106.87
84144 <1% 45 $72.07
84443 Thyroid stimulating hormone (TSH) <1% 12 $43.24
80076 <1% 13 $39.00
82248 <1% 19 $37.44
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 21 $16.00
80335 <1% 24 $14.05
80053 Comprehensive metabolic panel <1% 14 $12.00
80323 <1% 23 $4.11
85027 0% 31 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.